Advisory Board
Teresa Wilborn, PharmD, PhD
Dr. Teresa Wilborn is a Professor of Pharmacology at the University of Alabama at Birmingham (UAB) Heersink School of Medicine. She earned her PhD from UAB and has broad experience in pharmacology educator with extensive involvement in medical and graduate pharmacology education, curriculum development, and academic leadership. She previously served as Interim Chair of the Department of Pharmacology and Toxicology at UAB. Throughout her academic career, Dr. Wilborn has contributed to the education and training of future healthcare professionals and biomedical scientists through teaching, mentorship, and curriculum innovation. Her professional interests encompass pharmacology education, biomedical research, and the advancement of health professions training. Dr. Wilborn has received numerous prestigious teaching awards.
Dr. Christopher S. Breivogel, PhD
Dr. Christopher S. Breivogel is Professor and Chair of Pharmacology at the Jerry M. Wallace School of Osteopathic Medicine, Campbell University, North Carolina. He is an experienced pharmacologist, educator, and researcher with extensive expertise in neuropharmacology, cannabinoid pharmacology, and G-protein-coupled receptor signaling. His research focuses on the pharmacological mechanisms and physiological effects of cannabinoids, particularly their interactions with CB1 receptors in the central nervous system. His investigations also examine the neurobehavioral and toxicological effects of synthetic cannabinoids and their implications for human health. Dr. Breivogel has authored numerous peer-reviewed scientific publications and contributed to advancing understanding of the endocannabinoid system. In addition to his research accomplishments, he has extensive experience in medical and pharmaceutical education, curriculum development, and academic leadership, contributing to the training of future healthcare professionals and biomedical scientists.
Larry Walker, BSPharm, PhD
Dr. Larry A. Walker is Professor Emeritus of Pharmacology and former Director of the National Center for Natural Products Research at the University of Mississippi School of Pharmacy. He earned his pharmacy degree from Mercer University and a PhD in Pharmacology from Vanderbilt University. With over four decades of academic and research experience, Dr. Walker is a distinguished pharmacologist with extensive expertise in drug discovery, toxicology, and drug metabolism. His research has focused on the discovery and development of therapeutic agents, including antimalarial, anticancer, and antimicrobial compounds, as well as cannabinoid pharmacology. He has authored or coauthored more than 230 peer-reviewed publications and has served on numerous scientific advisory panels and editorial boards. His career reflects significant contributions to pharmaceutical research, drug discovery, and academic leadership.
Theophilus Gana, MD, PhD
Dr. Theophilus J. Gana is an experienced pharmaceutical physician-scientist and clinical drug development specialist with nearly three decades of experience in pharmaceutical research and clinical trials. He holds a PhD from the University of Alberta, Canada, and is affiliated with Biopharmatech Consulting, Inc., in Virginia, USA. His expertise encompasses clinical trial design and management, drug development, clinical pharmacology, and therapeutic evaluation. Dr. Gana has contributed to numerous clinical research programs across therapeutic areas, including cardiovascular diseases, diabetes, pain management, inflammatory disorders, and oncology. He has served in clinical development and consulting roles within the pharmaceutical industry and has contributed to peer-reviewed publications on drug efficacy, safety, and innovative clinical trial methodologies. His career reflects extensive experience in translating pharmaceutical research into clinical development and therapeutic innovation (https://kinexum.com/team-member/theophilus-gana-md-phd/)
Pius S. Fasinu, PhD, BCPS
Dr. Pius S. Fasinu is an Associate Professor of Pharmacology at the University of Alabama at Birmingham (UAB) Heersink School of Medicine. A licensed pharmacist and board-certified pharmacotherapy specialist, he has extensive experience in pharmacology education and curriculum leadership. He earned his PhD from Stellenbosch University, South Africa, and completed postdoctoral training at the University of Mississippi. His expertise encompasses clinical pharmacology, pharmacokinetics, drug metabolism, pharmacogenomics, and drug discovery and development. Dr. Fasinu teaches across multiple health professions programs and has developed innovative pharmacology curricula and continuing education programs. His research has resulted in numerous peer-reviewed publications. He contributes to national and international initiatives in pharmacology education, professional training, and continuing medical education.
